Us Bancorp \De\ Amneal Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

$82.9 Billion
Q3 2025

A detailed history of Us Bancorp \De\ transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 366 shares of AMRX stock, worth $4,260. This represents 0.0% of its overall portfolio holdings.

Number of Shares

366

Previous 484 24.38%

Holding current value

$4,260

Previous $3,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$7.82 - $10.09 $922 - $1,190	-118 Reduced 24.38%	366 $3,000
Q2 2025 Jul 23, 2025	BUY	$6.97 - $8.23 $104 - $123	15 Added 3.2%	484 $3,000
Q1 2025 May 08, 2025	BUY	$7.72 - $9.01 $1,520 - $1,774	197 Added 72.43%	469 $3,000
Q4 2024 Feb 05, 2025	BUY	$7.69 - $9.25 $907 - $1,091	118 Added 76.62%	272 $2,000
Q1 2024 May 07, 2024	SELL	$5.24 - $6.34 $2,321 - $2,808	-443 Reduced 74.2%	154 $0

Q4 2023 Feb 09, 2024	BUY	$3.36 - $6.21 $1,659 - $3,067	494 Added 479.61%	597 $3,000
Q3 2023 Nov 03, 2023	SELL	$2.76 - $4.59 $4,642 - $7,720	-1,682 Reduced 94.23%	103 $0
Q2 2023 Aug 09, 2023	BUY	$1.33 - $3.1 $609 - $1,419	458 Added 34.51%	1,785 $5,000
Q4 2022 Feb 13, 2023	BUY	$1.96 - $2.61 $2,369 - $3,155	1,209 Added 1024.58%	1,327 $2,000
Q3 2022 Oct 27, 2022	SELL	$2.02 - $3.62 $11,746 - $21,050	-5,815 Reduced 98.01%	118 $0
Q2 2022 Aug 01, 2022	BUY	$3.01 - $4.46 $15,384 - $22,795	5,111 Added 621.78%	5,933 $19,000
Q1 2022 May 11, 2022	SELL	$3.9 - $4.89 $230 - $288	-59 Reduced 6.7%	822 $3,000
Q4 2021 Feb 11, 2022	SELL	$3.95 - $5.85 $1,216 - $1,801	-308 Reduced 25.9%	881 $4,000
Q3 2021 Nov 10, 2021	BUY	$4.31 - $5.64 $499 - $654	116 Added 10.81%	1,189 $7,000
Q2 2021 Aug 05, 2021	SELL	$5.12 - $6.82 $1,884 - $2,509	-368 Reduced 25.54%	1,073 $5,000
Q1 2021 Apr 28, 2021	BUY	$4.74 - $7.38 $2,934 - $4,568	619 Added 75.3%	1,441 $10,000
Q3 2020 Nov 10, 2020	SELL	$3.54 - $5.27 $5,310 - $7,904	-1,500 Reduced 64.6%	822 $3,000
Q1 2020 May 13, 2020	BUY	$2.46 - $5.35 $4,501 - $9,790	1,830 Added 371.95%	2,322 $8,000
Q4 2019 Feb 04, 2020	SELL	$2.65 - $5.56 $376 - $789	-142 Reduced 22.4%	492 $2,000
Q3 2019 Nov 08, 2019	BUY	$2.29 - $7.1 $1,126 - $3,493	492 Added 346.48%	634 $2,000
Q2 2019 Aug 13, 2019	SELL	$6.44 - $14.29 $10,368 - $23,006	-1,610 Reduced 91.89%	142 $1,000
Q1 2019 May 08, 2019	BUY	$11.87 - $14.84 $1,246 - $1,558	105 Added 6.38%	1,752 $25,000
Q4 2018 Feb 13, 2019	SELL	$13.09 - $21.49 $3,233 - $5,308	-247 Reduced 13.04%	1,647 $22,000
Q3 2018 Nov 01, 2018	BUY	$16.4 - $24.27 $295 - $436	18 Added 0.96%	1,894 $42,000
Q2 2018 Aug 08, 2018	BUY	$13.95 - $20.2 $26,170 - $37,895	1,876 New	1,876 $31,000

Others Institutions Holding AMRX

# of Institutions

257

Shares Held

150M

Call Options Held

357K

Put Options Held

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.76B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account